Guangzhou, China

Shizhong Liang

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Bio-Thera Solutions, Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shizhong Liang. Retrieved from https://idiyas.com/inventor/shizhong-liang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shizhong Liang: Innovator in Antibody Research

Introduction

Shizhong Liang is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work is instrumental in advancing therapeutic options for various diseases.

Latest Patents

Shizhong Liang holds a patent for an "Antibody Binding to PD-1." This innovation is crucial in the ongoing research and development of cancer therapies, as PD-1 is a well-known target in immunotherapy.

Career Highlights

Liang is currently employed at Bio-Thera Solutions, Ltd., a company dedicated to developing innovative biopharmaceuticals. His role at the company allows him to leverage his expertise in antibody research to contribute to groundbreaking treatments.

Collaborations

Throughout his career, Shizhong Liang has collaborated with notable colleagues, including Haitao Yue and Jian Lin. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Shizhong Liang's contributions to antibody research and his innovative patent highlight his importance in the biotechnology field. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…